Cancer Biomarker Testing Market Research Insights 2022-28
January 11, 2023 ⚊ 1 Min read ⚊ Views 74 ⚊ BUSINESSCancer Biomarker Testing Market was valued at USD 10.42 billion in 2021 and is anticipated to grow at USD 20.59 billion by 2028 recording a CAGR of 12.4% during the forecast period 2022-2028. The cancer biomarker test market is driven by rising prevalence of cancer worldwide. World Health Organization (WHO) stated that cancer is one of the leading causes of mortality and morbidity worldwide, with approximately 14 Mn new cases in 2012.
Tags: Cancer Biomarker Testing Market